Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2025 pubmed 3 citations

Vitamin D and LL-37 in Serum and Saliva: Insights into Oral Immunity.

Davidopoulou. Sotiria S; Makedou. Kali K; Kourti. Areti A; Gkeka. Ioanna I; Karakostas. Panagiotis P; Pikilidou. Maria M; Tolidis. Kosmas K; Kalfas. Sotirios S

Key Findings

  • Serum vitamin D levels modestly correlate with serum LL-37 (r=0.328, p=0.005).
  • Salivary vitamin D levels strongly correlate with salivary LL-37 (r=0.667, p<0.001).
  • The stronger link in saliva points to a potentially important role of vitamin D in oral immunity.

Practical Outcomes

  • Maintaining adequate vitamin D may help support your mouth’s natural antimicrobial defenses via LL-37. Consider monitoring your vitamin D status and, if low, discuss supplementation with a healthcare provider. While promising, more research is needed before specific dosing or protocols can be recommended.

Summary

The study found that higher vitamin D levels in the blood and especially in saliva are linked to higher amounts of the antimicrobial peptide LL-37, which helps protect the mouth from germs. This suggests that keeping your vitamin D status up could boost your oral immune defenses, but the research is just a correlation and doesn’t prove that taking vitamin D will automatically raise LL-37.

Abstract

(1) Background: In recent years, there has been a growing interest in understanding the innate immunity of the mouth, particularly the mechanisms through which vitamin D influences oral health. Researchers have increasingly focused on the association between vitamin D and the antimicrobial peptide LL-37 since the CAMP gene, responsible for encoding the LL-37 peptide, is a direct target of both vitamin D and its receptor (vitamin D receptor, VDR). This study aimed to explore the correlation between the 25-hydroxyvitamin D (25(OH)D) levels and the concentration of the LL-37 peptide in both serum and saliva. The objective was to compare the serum concentrations of 25(OH)D and ll-37 with those in saliva and to access the correlations between the two compounds. (2) Methods: Serum and whole saliva samples were collected from 72 healthy adults (mean age 28.68 &#xb1; 8.35). The levels of 25(OH)D and LL-37 were assessed in both the saliva and serum samples using commercially available enzyme-linked immunosorbent assay (ELISA) kits. (3) Results: The 25(OH)D levels in the serum (median 5.92 ng/mL, min-max 2.7-10.4 ng/mL) correlated with the LL-37 serum levels (62 ng/mL, min-max 18-378 ng/mL; Pearson's r 0.328, <i>p</i> = 0.005). Additionally, the 25(OH)D levels in saliva (median 1.16 ng/mL, min-max 0.54-2.12 ng/mL) strongly correlated with the LL-37 salivary levels (median 44 ng/mL, min-max 6.5-205 ng/mL; Pearson's r 0.667, <i>p</i> &lt; 0.001). The 25(OH)D salivary levels demonstrated a robust correlation with the LL-37 salivary levels. (4) Conclusions: This discovery emphasizes the complex interplay between vitamin D and LL-37 and lay the groundwork for the further exploration of vitamin D's role in oral immune function.

Study Information

Provider

pubmed

Year

2025

Date

2025-02-06T00:00:00.000Z

DOI

10.3390/cimb47020102

Citations

3

References

47